We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$650B
$8.41M 1.43%
+76,291
New +$8.17M
BMY icon
2
Bristol-Myers Squibb
BMY
$126B
$8.03M 1.36%
+111,556
New +$8.41M
CAT icon
3
Caterpillar
CAT
$412B
$7.8M 1.32%
32,550
+6,207
+24% +$1.35M
CVS icon
4
CVS Health
CVS
$136B
$6.42M 1.09%
68,865
+174
+0.3% +$16.8K
LIN icon
5
Linde
LIN
$234B
$5.99M 1.02%
18,352
+8,295
+82% +$2.6M
NKE icon
6
Nike
NKE
$60.8B
$5.67M 0.96%
48,473
-25,517
-34% -$2.57M
MPC icon
7
Marathon Petroleum
MPC
$91.2B
$5.11M 0.87%
43,920
-11,765
-21% -$1.34M
PSX icon
8
Phillips 66
PSX
$83B
$5.1M 0.87%
49,010
+10,524
+27% +$1.08M
AMGN icon
9
Amgen
AMGN
$201B
$4.96M 0.84%
18,887
+11,195
+146% +$3M
EIX icon
10
Edison International
EIX
$30.6B
$4.87M 0.83%
76,596
+11,124
+17% +$683K
ICE icon
11
Intercontinental Exchange
ICE
$81B
$4.74M 0.8%
46,232
+10,212
+28% +$1.02M
LOW icon
12
Lowe's Companies
LOW
$113B
$4.71M 0.8%
23,644
-11,164
-32% -$2.23M
EBAY icon
13
eBay
EBAY
$48.5B
$4.69M 0.8%
113,106
-13,475
-11% -$558K
PPG icon
14
PPG Industries
PPG
$25.4B
$4.68M 0.79%
37,258
+5,228
+16% +$640K
V icon
15
Visa
V
$669B
$4.61M 0.78%
22,171
-16,894
-43% -$3.41M
MA icon
16
Mastercard
MA
$469B
$4.44M 0.75%
12,775
-8,466
-40% -$2.79M
HON icon
17
Honeywell
HON
$78B
$4.42M 0.75%
21,901
+17,262
+372% +$3.3M
ADBE icon
18
Adobe
ADBE
$84.3B
$4.13M 0.7%
+12,286
New +$3.93M
EXE
19
Expand Energy Corp
EXE
$21.9B
$4.09M 0.69%
43,319
-2,234
-5% -$221K
TXN icon
20
Texas Instruments
TXN
$260B
$4.05M 0.69%
+24,505
New +$4.09M
MAR icon
21
Marriott International
MAR
$96.1B
$4.03M 0.68%
27,073
+9,558
+55% +$1.47M
FTV icon
22
Fortive
FTV
$18.5B
$3.94M 0.67%
81,433
-4,634
-5% -$224K
AMZN icon
23
Amazon
AMZN
$2.51T
$3.93M 0.67%
46,743
-13,605
-23% -$1.34M
DFS
24
DELISTED
Discover Financial Services
DFS
$3.88M 0.66%
39,706
+15,220
+62% +$1.53M
NEM icon
25
Newmont
NEM
$101B
$3.84M 0.65%
81,354
+45,325
+126% +$2.02M

Similar funds

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.